Drug or treatment

Natalizumab clinical trials

• 2Clinical trials
• 1New in 30 days
• 2Countries

All recruiting trials (2)

• Natalizumab to help prevent brain-related side effects during CAR-T therapy in certain lymphoma patients

  This phase 2 study tests whether natalizumab can reduce severe ICANS in adults with recurrent or refractory DLBCL or MCL receiving CAR-T therapy.

  Recruiting Phase 2 University of Michigan Rogel Cancer Center · Ann Arbor, Michigan · NCT07892027

• Early natalizumab treatment for people with first signs of MS

  This trial will try giving natalizumab within 14 days of symptom onset to adults with a first presentation of MS or clinically isolated demyelination to see if very early treatment reduces inflammation and early disease activity.

  Recruiting Phase 2 Queen Mary University of London · London and 1 other locations · NCT05418010

Quick answers

How many clinical trials of Natalizumab are recruiting right now?

2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →